Omni Pharmaceuticals is Pharmaceuticals in China that focus on branded pharmaceuticals business. Founded in 2011. They cover business area such as manufacturer, chronic disease, Chronic Obstructive Pulmonary Disease, COPD, asthma, inhalation dry powder, nasal, HFA, release capsule, tablet, drug delivery system, regulated market, North America, Europe, China, their expertise, select public health challenge.
2011
( 13 years old in 2024 )
Branded Pharmaceuticals
-
8th Floor, Block B
Changtai Plaza, Pudong New Area
Shanghai, 201203
China
Private
manufacturerchronic diseaseChronic Obstructive Pulmonary DiseaseCOPDasthmainhalation dry powdernasalHFArelease capsuletabletdrug delivery systemregulated marketNorth AmericaEuropeChinatheir expertiseselect public health challenge
* We use standard office opening hours in near Omni Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Omni Pharmaceuticals is Pharmaceuticals business from China that founded in 2011 (13 years old in 2024), Omni Pharmaceuticals business is focusing on Branded Pharmaceuticals.
Omni Pharmaceuticals headquarter office and corporate office address is located in 8th Floor, Block B Changtai Plaza, Pudong New Area Shanghai, 201203 China.
Omni Pharmaceuticals was founded in China.
In 2024, Omni Pharmaceuticals is currently focus on branded pharmaceuticals sector.
Above is snippet of Google Trends for "branded pharmaceuticals" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Omni Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
